Headshot of Mahmoud Maina.

Mahmoud Bukar Maina

Junior group leader
Biomedical Science Research and Training Centre, Yobe State University and the University of Sussex

Mahmoud Bukar Maina holds dual roles as junior group leader at the Biomedical Science Research and Training Centre at Yobe State University in Nigeria and in the neuroscience department at the University of Sussex in the United Kingdom. His team’s research focuses on generating induced pluripotent stem cells from Indigenous African people for open-access biobanking and investigating the molecular mechanisms of tauopathies in the context of African genetic backgrounds.

In his previous work, Maina identified a critical function of tau in the nucleolus, which sparked his ongoing research on the potential role of ancestry-driven rDNA variations in nucleolar dysfunction in tauopathies. With more than a decade of experience in initiatives to strengthen African science, he sits on multiple local and international committees and serves as a science adviser for the Yobe State Government, where he advises various institutions and funders both within and beyond Africa. He has received several recognitions, including the ALBA-FKNE Diversity Prize for the promotion of basic neuroscience and the Royal Society’s Global Talent visa.

From this contributor

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read